Hakobyan R V, Mkhoyan G G
Department of Anesthesiology and Intensive Care, Yerevan State Medical University, Yerevan, Armenia.
Acta Clin Belg. 2008 Mar-Apr;63(2):86-92. doi: 10.1179/acb.2008.63.2.005.
Surgical decompression is a lifesaving procedure in patients with severe intraabdominal hypertension. However, it involves subsequent management of an open abdomen. Therefore, it is not recommended for moderate intra-abdominal hypertension. Our literature search did not show any studies relating the efficacy of epidural analgesia in decreasing elevated intraabdominal pressure (IAP) in critically-ill surgical patients with primary intra-abdominal hypertension.
Through a blinded prospective study, we investigated postoperative critically-ill surgical and trauma patients with primary intra-abdominal hypertension, who received postoperative thoracic epidural analgesia (n = 58) or intravenous opioid analgesia (n = 130). Patients in the epidural group received ropivacaine 0.2% 10 ml, followed by an infusion of 5 ml/h for 96 hours. Patients in the opioid group could receive morphine hydrochloride (0.1 mg/kg IV for every 4-6 hours as needed) with or without ketorolac trometamol (up to 90 mg/day IV). IAP was measured transvesically, for every 6 hours. Additionally, measurements immediately before and 1 hour after the initiation of epidural analgesia were taken. Abdominal Perfusion Pressure (APP) was calculated for each IAP measurement as APP = MAP - IAP where MAP is the mean arterial pressure.
In the epidural group we found a consistent decrease in IAP from 16.82 +/- 4.56 to 6.30 +/- 3.11 mmHg and an increase in APP from 60.26 +/- 21.893 to 76.10 +/- 17.54 mmHg between baseline values until the second day of epidural analgesia, which remained stable afterwards. There were no significant differences of IAP and APP in the opioid group.
Continuous thoracic epidural analgesia decreases IAP and improves APP without haemodynamic compromise in postoperative critically-ill patients with primary intra-abdominal hypertension.
手术减压是治疗严重腹腔内高压患者的救命措施。然而,术后需对开放腹腔进行后续处理。因此,不建议用于中度腹腔内高压患者。我们的文献检索未发现任何关于硬膜外镇痛对患有原发性腹腔内高压的重症外科患者降低升高的腹腔内压力(IAP)疗效的研究。
通过一项双盲前瞻性研究,我们调查了术后患有原发性腹腔内高压的重症外科和创伤患者,这些患者接受了术后胸段硬膜外镇痛(n = 58)或静脉注射阿片类镇痛(n = 130)。硬膜外组患者接受0.2%罗哌卡因10 ml,随后以5 ml/h的速度输注96小时。阿片类组患者可根据需要每4 - 6小时静脉注射盐酸吗啡(0.1 mg/kg),可加用或不加用酮咯酸氨丁三醇(静脉注射每日最高90 mg)。每6小时经膀胱测量IAP。此外,在硬膜外镇痛开始前及开始后1小时进行测量。每次IAP测量时计算腹腔灌注压(APP),APP = 平均动脉压(MAP)- IAP。
在硬膜外组,我们发现从基线值到硬膜外镇痛第二天,IAP持续下降,从16.82±4.56 mmHg降至6.30±3.11 mmHg,APP从60.26±21.893 mmHg升至76.10±17.54 mmHg,此后保持稳定。阿片类组的IAP和APP无显著差异。
持续胸段硬膜外镇痛可降低患有原发性腹腔内高压的术后重症患者的IAP并改善APP,且无血流动力学损害。